These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11697756)

  • 1. Pharmacokinetics of norelgestromin and ethinyl estradiol from two consecutive contraceptive patches.
    Abrams LS; Skee DM; Wong FA; Anderson NJ; Leese PT
    J Clin Pharmacol; 2001 Nov; 41(11):1232-7. PubMed ID: 11697756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of a contraceptive patch (Evra/Ortho Evra) containing norelgestromin and ethinyloestradiol at four application sites.
    Abrams LS; Skee DM; Natarajan J; Wong FA; Anderson GD
    Br J Clin Pharmacol; 2002 Feb; 53(2):141-6. PubMed ID: 11851637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of norelgestromin and ethinyl estradiol delivered by a contraceptive patch (Ortho Evra/Evra) under conditions of heat, humidity, and exercise.
    Abrams LS; Skee DM; Natarajan J; Wong FA; Leese PT; Creasy GW; Shangold MM
    J Clin Pharmacol; 2001 Dec; 41(12):1301-9. PubMed ID: 11762557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic overview of Ortho Evra/Evra.
    Abrams LS; Skee D; Natarajan J; Wong FA
    Fertil Steril; 2002 Feb; 77(2 Suppl 2):S3-12. PubMed ID: 11849630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal contraception.
    Creasy GW; Abrams LS; Fisher AC
    Semin Reprod Med; 2001 Dec; 19(4):373-80. PubMed ID: 11727179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants.
    Abrams LS; Skee DM; Natarajan J; Wong FA; Lasseter KC
    Contraception; 2001 Nov; 64(5):287-94. PubMed ID: 11777488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of 12-week continuous contraceptive patch use.
    Lavelanet AF; Rybin D; White KO
    Contraception; 2017 Jun; 95(6):578-585. PubMed ID: 28285154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Evra (ethinyl estradiol/norelgestromin) contraceptive patch: estrogen exposure concerns.
    Wooltorton E
    CMAJ; 2006 Jan; 174(2):164-5. PubMed ID: 16368722
    [No Abstract]   [Full Text] [Related]  

  • 9. Ortho Evra/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error.
    Pierson RA; Archer DF; Moreau M; Shangold GA; Fisher AC; Creasy GW
    Fertil Steril; 2003 Jul; 80(1):34-42. PubMed ID: 12849799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra).
    Sibai BM; Odlind V; Meador ML; Shangold GA; Fisher AC; Creasy GW
    Fertil Steril; 2002 Feb; 77(2 Suppl 2):S19-26. PubMed ID: 11849632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive.
    Devineni D; Skee D; Vaccaro N; Massarella J; Janssens L; LaGuardia KD; Leung AT
    J Clin Pharmacol; 2007 Apr; 47(4):497-509. PubMed ID: 17389559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions.
    Zacur HA; Hedon B; Mansour D; Shangold GA; Fisher AC; Creasy GW
    Fertil Steril; 2002 Feb; 77(2 Suppl 2):S32-5. PubMed ID: 11849634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188.
    Vogler MA; Patterson K; Kamemoto L; Park JG; Watts H; Aweeka F; Klingman KL; Cohn SE
    J Acquir Immune Defic Syndr; 2010 Dec; 55(4):473-82. PubMed ID: 20842042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception.
    Goa KL; Warner GT; Easthope SE
    Treat Endocrinol; 2003; 2(3):191-206. PubMed ID: 15966567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic overview of ethinyl estradiol dose and bioavailability using two transdermal contraceptive systems and a standard combined oral contraceptive.
    Hofmann B; Reinecke I; Schuett B; Merz M; Zurth C
    Int J Clin Pharmacol Ther; 2014 Dec; 52(12):1059-70. PubMed ID: 25295716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of efavirenz on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy HIV-negative women.
    Sevinsky H; Eley T; Persson A; Garner D; Yones C; Nettles R; Krantz K; Bertz R; Zhang J
    Antivir Ther; 2011; 16(2):149-56. PubMed ID: 21447863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women.
    Archer DF; Bigrigg A; Smallwood GH; Shangold GA; Creasy GW; Fisher AC
    Fertil Steril; 2002 Feb; 77(2 Suppl 2):S27-31. PubMed ID: 11849633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial.
    Stewart FH; Kaunitz AM; Laguardia KD; Karvois DL; Fisher AC; Friedman AJ
    Obstet Gynecol; 2005 Jun; 105(6):1389-96. PubMed ID: 15932834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of laropiprant, a PGD2 receptor 1 antagonist, on estradiol and norgestimate pharmacokinetics after oral contraceptive administration in women.
    Schwartz JI; Liu F; Wang YH; Pramanik B; Johnson-Levonas AO; Gutierrez MJ; Lai E; Wagner JA
    Am J Ther; 2009; 16(6):487-95. PubMed ID: 19940609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a transdermal contraceptive patch with a newly sourced adhesive component versus EVRA patch: A double-blind, randomized, bioequivalence and adhesion study in healthy women.
    Parasrampuria DA; Vaughan S; Ariyawansa J; Swinnen A; Natarajan J; Rasschaert F; Massarella J; Fonseca S
    Contraception; 2020 Apr; 101(4):276-282. PubMed ID: 31935382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.